BSX — BOSTON SCIENTIFIC CORP

Ownership history in Man Group plc  ·  31 quarters on record

This page tracks every 13F SEC filing in which Man Group plc reported a position in BOSTON SCIENTIFIC CORP (BSX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.71% (2025 Q4)
Avg. % of fund
0.11%
First filed
2018 Q1
Last filed
2025 Q4
Quarters held
31
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 4,392,725 +548,788 +14.3% 0.71% $418.8M $95.35
2025 Q3 ADDED 3,843,937 +1,706,494 +79.8% 0.65% $375.3M $97.63
2025 Q2 ADDED 2,137,443 +1,308,711 +157.9% 0.44% $229.6M $107.41
2025 Q1 ADDED 828,732 +557,673 +205.7% 0.21% $83.6M $100.88
27 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    BSX price (monthly, adj. close)

Other funds also holding BSX

As of 2025 Q4 — sorted by position size

Bollard Group LLC 3Y 7Y 45.28% SurgoCap Partners LP 6.76% Tri Locum Partners LP 3Y 6.44% ECOFI INVESTISSEMENTS SA 6.18% Catalio Capital Management, LP 6.07% Egerton Capital (UK) LLP 3Y 7Y 5.58% FACT Capital, LP 3Y 5.11% ORBIMED ADVISORS LLC 3Y 7Y 4.71% Iron Triangle Partners LP 3Y 4.59% Parkman Healthcare Partners LLC 3Y 4.54%
← Back to Man Group plc Holdings